Evidence map›Paper›PMID 34470529›Full record

ArticleSeminars in cardiothoracic and vascular anesthesia2022

Corticosteroid Administration and Impaired Glycemic Control in Mechanically Ventilated COVID-19 Patients.

David J Douin, Martin Krause, Cynthia Williams, Kenji Tanabe, Ana Fernandez-Bustamante, Aurora N Quaye, Adit A Ginde, Karsten Bartels

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Seminars in cardiothoracic and vascular anesthesia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

David J DouinUniversity of Colorado, School of Medicine, Aurora, CO, USA.
Martin KrauseUniversity of Colorado, School of Medicine, Aurora, CO, USA.
Cynthia WilliamsUniversity of Colorado, School of Medicine, Aurora, CO, USA.
Kenji TanabeUniversity of Colorado, School of Medicine, Aurora, CO, USA.
Ana Fernandez-BustamanteUniversity of Colorado, School of Medicine, Aurora, CO, USA.
Aurora N QuayeMaine Medical Center, Portland, ME, USA.
Adit A GindeUniversity of Colorado, School of Medicine, Aurora, CO, USA.
Karsten BartelsUniversity of Colorado, School of Medicine, Aurora, CO, USA.ORCID https://orcid.org/0000-0003-2028-4664
University of Colorado Denver · USMaine Medical Center · USOutcomes Research Consortium · US

Funding

Efficiency And Quality In Post-Surgical Pain Therapy After Discharge - EQUIPPEDR01HS027795 · AHRQ · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BARTELS, KARSTEN · 2021 to 2024
$1.6M
Anesthesiology Mentored Research TrainingT32GM135169 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI Susan L Ingram, Vesna Jevtovic-Todorovic · 2021 to 2026
$1.0M
Improving Opioid Prescription Safety After SurgeryK23DA040923 · NIDA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI BARTELS, KARSTEN · 2016 to 2020
$945k
AHRQ HHS R01 HS027795NIDA NIH HHS K23 DA040923NIGMS NIH HHS T32 GM135169
6 · The paper itself

Abstract

objectiveRecent clinical trials confirmed the corticosteroid dexamethasone as an effective treatment for patients with COVID-19 requiring mechanical ventilation. However, limited attention has been given to potential adverse effects of corticosteroid therapy. The objective of this study was to determine the association between corticosteroid administration and impaired glycemic control among COVID-19 patients requiring mechanical ventilation and/or veno-venous extracorporeal membrane oxygenation.

designMulticenter retrospective cohort study between March 9 and May 17, 2020. The primary outcome was days spent with at least 1 episode of blood glucose either >180 mg/dL or <80 mg/dL within the first 28 days of admission.

settingTwelve hospitals in a United States health system. PATIENTS: Adults diagnosed with COVID-19 requiring invasive mechanical ventilation and/or veno-venous extracorporeal membrane oxygenation.

interventionsNone. MEASUREMENTS AND MAIN

resultsWe included 292 mechanically ventilated patients. We fitted a quantile regression model to assess the association between steroid administration ≥320 mg methylprednisolone (equivalent to 60 mg dexamethasone) and impaired glycemic control. Sixty-six patients (22.6%) died within 28 days of intensive care unit admission. Seventy-one patients (24.3%) received a cumulative dose of least 320 mg methylprednisolone equivalents. After adjustment for gender, history of diabetes mellitus, chronic liver disease, sequential organ failure assessment score on intensive care unit day 1, and length of stay, administration of ≥320 mg methylprednisolone equivalent was associated with 4 additional days spent with glucose either <80 mg/dL or >180 mg/dL (B = 4.00, 95% CI = 2.15-5.85,

conclusionsIn this cohort study of 292 mechanically ventilated COVID-19 patients, we found an association between corticosteroid administration and higher incidence of both hyperglycemia and hypoglycemia.

Indexed as

COVID-19Adrenal Cortex HormonesAdultCohort StudiesGlycemic ControlHumansRespiration, ArtificialRetrospective StudiesSARS-CoV-2Adrenal Cortex HormonescorticosteroidsCOVID-19dexamethasoneglycemic controlhyperglycemiahypoglycemiamechanical ventilation

Identifiers

PMID34470529
PMCPMC8927893
OpenAlexW3196585943

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.